TARDBP and amyotrophic lateral sclerosis: All participants with FTLD-TDP or regional TDP-43 scores had TDP-43 antibody (NPTDPAN) reported, in contrast with a substantial number of participants with assessment for HS-A (N = 686) and ALS (N = 645) which did not have a TDP-43 antibody listed.